TDOC Valuation

Teladoc Health Inc

Add to Watchlist

Advanced Chart

6.840

+0.06(0.885%)1D

Overview
Forecast
Valuation
Earnings

TDOC Relative Valuation

TDOC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, TDOC is overvalued; if below, it's undervalued.

Historical Valuation

Teladoc Health Inc (TDOC) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.49 is considered Undervalued compared with the five-year average of -48.95. The fair price of Teladoc Health Inc (TDOC) is between 9.42 to 11.72 according to relative valuation methord. Compared to the current price of 6.83 USD , Teladoc Health Inc is Undervalued By 27.44%.

Relative Value

Fair Zone

9.42-11.72

Current Price：6.83

27.44%

Undervalued

-6.44

Trailing

Forward

5.65

EV/EBITDA

Teladoc Health Inc. (TDOC) has a current EV/EBITDA of 5.65. The 5-year average EV/EBITDA is 38.72. The thresholds are as follows: Strongly Undervalued below -46.52, Undervalued between -46.52 and -3.90, Fairly Valued between 81.34 and -3.90, Overvalued between 81.34 and 123.96, and Strongly Overvalued above 123.96. The current Forward EV/EBITDA of 5.65 falls within the Historic Trend Line -Fairly Valued range.

-8.50

EV/EBIT

Teladoc Health Inc. (TDOC) has a current EV/EBIT of -8.50. The 5-year average EV/EBIT is -135.26. The thresholds are as follows: Strongly Undervalued below -963.40, Undervalued between -963.40 and -549.33, Fairly Valued between 278.81 and -549.33, Overvalued between 278.81 and 692.87, and Strongly Overvalued above 692.87. The current Forward EV/EBIT of -8.50 falls within the Historic Trend Line -Fairly Valued range.

0.49

Teladoc Health Inc. (TDOC) has a current PS of 0.49. The 5-year average PS is 4.51. The thresholds are as follows: Strongly Undervalued below -5.96, Undervalued between -5.96 and -0.72, Fairly Valued between 9.74 and -0.72, Overvalued between 9.74 and 14.97, and Strongly Overvalued above 14.97. The current Forward PS of 0.49 falls within the Historic Trend Line -Fairly Valued range.

4.00

P/OCF

Teladoc Health Inc. (TDOC) has a current P/OCF of 4.00. The 5-year average P/OCF is 54.04. The thresholds are as follows: Strongly Undervalued below -88.92, Undervalued between -88.92 and -17.44, Fairly Valued between 125.51 and -17.44, Overvalued between 125.51 and 196.99, and Strongly Overvalued above 196.99. The current Forward P/OCF of 4.00 falls within the Historic Trend Line -Fairly Valued range.

6.65

P/FCF

Teladoc Health Inc. (TDOC) has a current P/FCF of 6.65. The 5-year average P/FCF is 79.99. The thresholds are as follows: Strongly Undervalued below -129.05, Undervalued between -129.05 and -24.53, Fairly Valued between 184.51 and -24.53, Overvalued between 184.51 and 289.03, and Strongly Overvalued above 289.03. The current Forward P/FCF of 6.65 falls within the Historic Trend Line -Fairly Valued range.

Teladoc Health Inc (TDOC) has a current Price-to-Book (P/B) ratio of 0.88. Compared to its 3-year average P/B ratio of 1.22 , the current P/B ratio is approximately -28.17% higher. Relative to its 5-year average P/B ratio of 1.89, the current P/B ratio is about -53.61% higher. Teladoc Health Inc (TDOC) has a Forward Free Cash Flow (FCF) yield of approximately 23.72%. Compared to its 3-year average FCF yield of 12.63%, the current FCF yield is approximately 87.88% lower. Relative to its 5-year average FCF yield of 7.80% , the current FCF yield is about 204.02% lower.

0.88

P/B

Median3y

1.22

Median5y

1.89

23.72

FCF Yield

Median3y

12.63

Median5y

7.80

Competitors Valuation Multiple

The average P/S ratio for TDOC's competitors is 1.19, providing a benchmark for relative valuation. Teladoc Health Inc Corp (TDOC) exhibits a P/S ratio of 0.49, which is -59.07% above the industry average. Given its robust revenue growth of -1.64%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Pediatrix Medical Group Inc

Aveanna Healthcare Holdings Inc

US Physical Therapy Inc

Performance Decomposition

Market capitalization of TDOC decreased by 5.44% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -3.07 to -5.90.

The secondary factor is the Revenue Growth, contributed -1.64%to the performance.

Overall, the performance of TDOC in the past 1 year is driven by P/E Change. Which is more unsustainable.

-1.64%

642.44M → 631.90M

Revenue Growth

-96.03%

-130.39 → -5.17

Margin Expansion

92.23%

-3.07 → -5.90

P/E Change

-5.44%